Thyroid-Stimulating Hormone Receptor Antibodies in Refractory Graves’ Disease Change Differently According to the Type of Definitive Therapy Administered

xlomafota13 shared this article with you from Inoreader Thyroid-Stimulating Hormone Receptor Antibodies in Refractory Graves' Disease Change Differently According to the Type of Definitive Therapy Administered Via Clinical Thyroidology Clinical Thyroidology, Volume 33, Issue 8, Page 350-353, August 2021. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.